Login to Your Account

Bonesupport raises $37M to advance drug-device Cerament

By Nuala Moran
Staff Writer

Monday, October 31, 2016

LONDON – Bonesupport AB has raised $37 million in private equity and debt to develop a pipeline of products that use its injectable biomimetic scaffold Cerament to deliver drugs to the bone and to fund clinical trials in new applications.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription